Skip to content
Screener

Price / book at other companies

Schrodinger logo
SchrodingerSDGR
3.7×-0.7×
PVL
Palvella TherapeuticsPVLA
7.7×+2.0×
Recursion Pharmaceuticals, Inc. logo
Recursion Pharmaceuticals, Inc.RXRX
2.1×-0.2×
Celcuity logo
CelcuityCELC
103.1×+98.7×
Revolution Medicines, Inc. logo
Revolution Medicines, Inc.RVMD
15.3×+11.3×
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
6.5×+3.8×

Other financials

Income statement

See full
Revenue$350.0K-48.3%
Operating income-$90.8M-18.2%
Net income-$83.7M-18.9%
EPS (diluted)-$0.410.0%

Balance sheet

See full
Cash & equivalents$121.2M+6.4%
Total debt$30.7M-10.3%
Total equity$890.0M+33.7%
Total assets$967.5M+32.7%

Cash flow

See full
Operating cash flow-$54.1M+2.1%
CapEx$1.0K
Free cash flow-$44.9M+22.5%

Valuation

See full
Market cap$4.3B+611%
Enterprise value$4.21B+702%
P/S415.9×+343×

Profitability

See full
Operating margin-2,999.4%-637pp
Net margin-2,763.6%-568pp
FCF margin-1,536%-429pp

Returns & leverage

See full
Return on equity-36.8%-6.3pp
Debt / equity0.0×
Current ratio18.3×-2.7×

Where this comes from

Calculated from Relay Therapeutics, Inc.’s reported figures.

Based on the most recent quarter.

The source filing: Relay Therapeutics, Inc.’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 6, 2026, 4:15 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-338056

FAQ

What is Relay Therapeutics, Inc.'s price / book?
Relay Therapeutics, Inc. (RLAY) reported price / book of 4.6× in Q2 2026.
How has Relay Therapeutics, Inc.'s price / book changed year-over-year?
Relay Therapeutics, Inc.'s price / book increased by 437.4% year-over-year, from 0.9× to 4.6×.
What is the long-term trend for Relay Therapeutics, Inc.'s price / book?
Over 5 years (2020 to 2025), Relay Therapeutics, Inc.'s price / book has grown at a -12.0% compound annual growth rate (CAGR), from 4.9× to 2.6×.
What does price / book mean?
Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.

Ask your AI about Relay Therapeutics, Inc.'s price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude